Investment Thesis
Neuronetics exhibits exceptional revenue growth (+99.2% YoY) with healthy gross margins (46.9%), but fundamentals are severely compromised by negative operating cash flow (-$9.4M), high leverage (4.62x Debt/Equity), and inability to cover interest expenses. At current burn rates with only $13.2M cash, financial distress risk is substantial despite improving loss trajectory.
Strengths
- Exceptional top-line growth at 99.2% YoY demonstrates strong market demand
- Solid gross margin of 46.9% indicates pricing power and viable unit economics
- Improving loss per share trend (+57.2% YoY) suggests operational path toward profitability
Risks
- Negative operating cash flow (-$9.4M) and negative free cash flow (-$9.6M) are unsustainable
- Extreme leverage of 4.62x Debt/Equity with only $13.3M stockholders equity and $61.3M long-term debt creates financial distress risk
- Negative interest coverage (-4.0x) indicates inability to service debt from operations; cash runway approximately 1.4 years at current burn rate
- Operating margin of -26.1% shows growth is not yet profitable despite rapid scaling
- High insider activity (24 Form 4 filings in 90 days) warrants scrutiny regarding confidence
Key Metrics to Watch
- Time to operating profitability and path to positive operating margins
- Operating cash flow trajectory and time to positive FCF generation
- Debt refinancing needs and debt maturity schedule relative to cash position
- Gross margin sustainability as revenue scales and operating leverage improvement
Financial Metrics
Revenue
34.5M
Net Income
-10.8M
EPS (Diluted)
$-0.16
Free Cash Flow
-9.6M
Total Assets
125.4M
Cash
13.2M
Profitability Ratios
Gross Margin
46.9%
Operating Margin
-26.1%
Net Margin
-31.3%
ROE
-81.3%
ROA
-8.6%
FCF Margin
-27.9%
Balance Sheet & Liquidity
Current Ratio
1.67x
Quick Ratio
1.50x
Debt/Equity
4.62x
Debt/Assets
86.4%
Interest Coverage
-3.97x
Long-term Debt
61.3M
Disclaimer: This analysis is generated by AI based on publicly available SEC EDGAR filings.
It does not include stock price data and should not be considered financial advice.
All fundamental data is sourced from SEC public domain filings.
Always conduct your own research before making investment decisions.
Data Source: SEC EDGAR |
Analysis Date: 2026-05-07T10:40:29.033158 |
Data as of: 2026-03-31 |
Powered by Claude AI